SEC Filing Form 4

This filing details the disposition of securities by Ellen Rosenberg, Chief Legal Officer of AMICUS THERAPEUTICS, INC. (FOLD), on April 27, 2026. The transactions, occurring in connection with the acquisition of the issuer by BioMarin Pharmaceutical Inc., involved the disposal of 463,898 shares of Common Stock and 15,000 shares of Common Stock held by spouse. Additionally, various stock options were cancelled and converted into cash payments. These options, totaling hundreds of thousands of shares, were fully vested at the time of the merger. All reported transactions resulted in a post-transaction ownership of zero shares for the reporting individual. The filing indicates that the securities were not subject to Section 16 of the Securities Exchange Act of 1934.